X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Promising Excipient&Dosage Market and Rigid Social Demand for BPCs

Yuvraj_pawp by Yuvraj_pawp
22nd February 2016
in Facilities & Operation

CPhI China, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 21 – 23rd June 2016 in Shanghai New International Expo Center. After fifteen years of experience and accumulation, CPhI China 2016 is poised for a larger size of exhibition, more elaborate zoning division and richer conferences and activities in the corresponding period, which is bound to be a splendid, high-end and unprecedented annual event in China’s pharmaceutical industry.

Rising momentum in BPC export as always
In the first three quarters in 2015, the gross amount of import and export of western medicine slowed down, growing as little as 2.19% YoY. However, the rigid demand in export remained unchanged. Data showed that the demand for western medicine in North America, Europe, Asia and other major export markets continued increasing steadily remained and Chinese BPC export accounted for as high as 81.6%. Therefore, China has kept its position as the largest BPC supplier. Besides, the State Council had deployed policies and measures to boost foreign trade growth in July 2015, supplying a system support for the sustainable growth in China’s drug import and export. Under these circumstances, CPhI China is expected to continue to give full play to itsexport oriented advantages and build a global one-stop pharmaceutical trading platform.

Well-developedproduct zoning and potential industrial development
Located in Shanghai New International Expo Center, CPhI China 2016 is expected to cover over 200,000m2 of the area and attract over 65,000 visits from both, China and abroad.The show provides end-to-end scope experience, including pharmaceutical ingredients, pharmaceutical excipients&dosages, contracting, biotechnology, natural extracts, intermediates, industry of fine chemicals, etc. The most anticipated zone in 2016 will beExcipient &Dosage. It is well known that this product zone is popular in the pharmaceutical industry nowadays. Accounting for over 80% of a drug in its content, the quality of pharmaceutical excipient determines the risks of drug safety and plays a key role in the quality of dosages. Excipient &Dosagezone– a main push of CPhI China — has been well-established after two years of growth. So far, the zone has converged North China Pharmaceutical, Huahai Pharmaceutical, Qilu Pharmaceutical, CSPC, Hisoar Pharmaceutical, Shijiazhuang No.4 Pharmaceutical, Livzon Pharmaceutical, Sunhere Pharmaceutical, NKY Pharmaceutical, ER-KANG Pharmaceutical, Xinhua Pharmaceutical and other domestically well-known excipient and dosage makers.

Rich onsite conference program and forums covering the latest trends
A series of high-quality conferences and forums will take place during CPhI China, bringing the latest market news for exhibitors and visitors, as well as establishing the platform for mutual study, dialogue, communication and rendering perfect chances for industry peers to build abundant interpersonal links. The well-established forums, built years under CPhI China brand, including the Seventh China-World CEO Summit, CPhI, ICSE & P-MEC China Innovation & Development Forum, CPhI International Agencies Updates, etc., will focus on methods to tackle fluctuating global pharmaceutical patterns and analyze relevant problems of supervision, policy, etc. in pharmaceutical transformation and upgrading, committed to help pharmaceutical companies further enhancing their competitiveness.

Exhibiting Profile

  • General zone: pharmaceutical ingredients, antibiotics, alkaloids, amino acids, etc.
  • Excipient, formulation and dosage zone: preservatives, emulgators/ solubilizers, microcapsules, solvents, pharmaceutical chemicals, TCMs, TCM ingredients, TCM decoction pieces, OTC drugs, biopharmaceutical product, biological product, health products, etc. 
  • ICSE zone: Composite customization, pre-clinical and clinical test, technology development/optimization, customized manufacturing, etc. 
  • BioPh zone: Protein/ antigen/ polypeptide, enzyme, protein purification/ modification/ inspection/ analysis, biological preparations, vaccines, antibodies, etc. 
  • NEX zone: Plant extracts, animal extracts, health product ingredients, TCM ingredients, etc. 
  • Intermediates and fine chemical zone: Intermediates (general classification), biocatalysts, chiral intermediates, fine chemical industry (general classification), etc.


Online visitor registration is now open! Please visit http://www.cphi.com/china to register or contact Ms. Tina Zheng (tina.zheng@ubmsinoexpo.com) for more information.

Previous Post

Quality and Clean Room Microenvironment Created by Innovation: EP & Clean Tech China launches the Discovery Tour onAir Treatment

Next Post

AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds

Related Posts

New Concept Allows Physical Partnering Event
Facilities & Operation

New Concept Allows Physical Partnering Event

11th September 2020
Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of Real-World Evidence in Oncology
Facilities & Operation

Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of Real-World Evidence in Oncology

27th September 2019
Catalent To Open New Clinical Supply Facility In San Diego
Drug Development

Catalent To Open New Clinical Supply Facility In San Diego

17th September 2019
IQVIA MedTech
Facilities & Operation

IQVIA Launches IQVIA MedTech Dedicated to Medical Device and Diagnostics Industry

14th May 2019
Catalent Invests $14 Million At Its Eberbach, Germany Softgel Facility
Facilities & Operation

Catalent Invests $14 Million At Its Eberbach, Germany Softgel Facility

24th April 2019
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease
Facilities & Operation

Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease

1st March 2019
Next Post

AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds

Latest News

Envirotainer introduces the RAP for the future - part of the Releye series
Packaging & Logistic

Envirotainer introduces the RAP for the future – part of the Releye series

14th February 2022
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
Packaging & Logistic

Opticooler receives technical approval by Japanese major airlines

14th February 2022
Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease
Press Statements

Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease

14th February 2022
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Drones for Delivery To Carry Pharmaceutical Weight Forward
News

Drones for Delivery To Carry Pharmaceutical Weight Forward

9th February 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In